Merck & Company, Inc.
MRK
Jodie situation report
Merck & Company, Inc.'s move is being confirmed by its market group.
MRK accounts for 17.2% of the group's measured movement across 7.8 effective names. raw member direction is mixed; 6 of 12 SPY-adjusted paths align to the downside. Capital-flow agreement is 41%, so confirmation is not yet clean. No verified headline preceded the measured group move.
Is this move genuinely shared?
MRK was the first measured mover. MRK crossed its material path threshold at 10:40 ET. ACAD, EXEL, BMY followed.
8 of 15 members in Biopharmaceuticals and Care are active. 0 of 8 disclosed connections are confirming.
- At least 10 of 15 durable members become active together.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as ABBV begins moving with the group.
Invalidation: The live read weakens if participation falls to 5 of 15 members or fewer.
Who this business touches
The relationships behind MRK
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
Depended on by
IBRXImmunityBio, Inc.supplierMay 7, 2026 ▾
“This addresses a significant supply challenge: TICE BCG (Merck) has been the sole supplier of BCG product in the U.S.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 34 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
MRK is currently a Participant in the organic co-movement group Biopharmaceuticals and Care. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.